Document is current
Any future updates will be listed below
-
Authors
Amodio, V.
Vitiello, P. P.
Bardelli, A. http://orcid.org/0000-0003-1647-5070
Germano, G. http://orcid.org/0000-0003-1688-8684
- License Information
-
More Information
Article History
Received: 16 April 2024
Revised: 26 August 2024
Accepted: 2 September 2024
First Online: 13 September 2024
Competing interests
: GG and AB are co-founders and shareholders of NeoPhore. AB reports receipt of grants/research support from Neophore, AstraZeneca and Boehringer Ingelheim and honoraria/consultation fees from Guardant Health and Inivata. AB is a stock shareholder of Kither Biotech. Alberto Bardelli is advisory board member for Inivata, Neophore, Roche/Genentech. The remaining authors declare no competing interests.
